Rybelsus is a GLP-1 receptor agonist that improves blood glucose control in type 2 diabetes by stimulating insulin secretion and reducing appetite
However, this weight loss is less pronounced in those with DM2, suggesting that factors like insulin resistance and constant high blood sugar reduce the effectiveness of these drugs
It is important to reach a stable weight safely before surgery to ensure optimal healing and long-lasting results
Along with the increased secretion of proinflammatory cytokines (TNF- and IL-6), adipose tissue macrophage infiltration and activation contribute to insulin resistance and impaired insulin signalling
Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY et al (2024) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial